Cannabis Market Intelligence

Q2 2026 Industry Report

A historic public listing and the opening of a federal rescheduling hearing mark a pivotal quarter for cannabis

Q2 2026 brought two developments that could reshape the cannabis industry’s path forward: a historic public-market listing for a major multi-state operator and the opening of a federal hearing on adult-use rescheduling. Capital markets and deal activity responded in kind. This report examines what these shifts mean for valuations, M&A, and competitive positioning across the cannabis landscape.

#image_title

What's Inside the Q2 2026 Cannabis Industry Report

Market Trends & Operating Performance

  • How one operator’s historic exchange listing is reshaping the pathway to public markets for plant-touching companies
  • What the DEA’s adult-use rescheduling hearing signals for the pace of federal reform

Financial Performance & Valuation Insights

  • How multi-state operator earnings and capital discipline strategies evolved this quarter
  • Where public market multiples stand as the industry awaits the hearing’s outcome

M&A Activity & Consolidation

  • What’s driving steady deal volume even as broader capital markets activity fluctuates
  • How the mix between strategic and financial buyers shifted in Q2

Regulatory & Policy Developments

  • What’s at stake in Pennsylvania’s and Virginia’s ongoing legalization efforts
  • Why Florida’s path to adult-use legalization remains closed for the foreseeable future

Get Your Cannabis Industry Report

Complete the form below to instantly access the comprehensive Q2 2026 Cannabis Market Intelligence Report:


By downloading this report, you agree to receive future cannabis industry intelligence reports and related market insights from Houlihan Capital. Unsubscribe any time.

Houlihan Capital Industry Update: Cannabis Market Q2 2026 banner over cannabis leaves with contact info at bottom
Team of professionals collaborating with laptops and notebooks, overlaid by a city skyline reflection.”

About Houlihan Capital's Cannabis Expertise

For over 25 years, Houlihan Capital has provided specialized financial services to cannabis businesses across cultivation, retail, processing, and ancillary services. Our team understands the unique valuation challenges, regulatory complexities, and strategic considerations that define success in this rapidly evolving industry.

Cannabis Services: Business Valuations | Fairness Opinions | Transaction Advisory | Exit Planning | Compliance-Ready Financial Analysis

Questions? Contact our cannabis specialists at info@houlihancapital.com or 312.450.8600

This content is for informational purposes only and does not constitute investment or legal advice. Always consult qualified professionals regarding cannabis business operations and compliance.